Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,404.00
Bid: 12,404.00
Ask: 12,406.00
Change: 44.00 (0.36%)
Spread: 2.00 (0.016%)
Open: 12,330.00
High: 12,422.00
Low: 12,316.00
Prev. Close: 12,360.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Britain approves Moderna's COVID-19 vaccine, eyes spring rollout

Fri, 08th Jan 2021 12:31

* Moderna shot becomes third to get UK regulatory approval

* UK increases order of Moderna shots to 17 million doses

* Moderna vaccine to be available in UK from the spring
(Adds Moderna statement, detail)

By Alistair Smout

LONDON, Jan 8 (Reuters) - Britain's medical regulator on
Friday approved Moderna's COVID-19 vaccine for use, the
health ministry said, adding that it had agreed to purchase an
additional 10 million doses as it eyed a spring rollout of the
shot.

Three COVID-19 vaccines have now been approved for use in
Britain, with Pfizer/BioNTech's shot and one
developed by Oxford University and AstraZeneca already
being administered.

The Moderna shot is not expected to play a part in the first
stage of Britain's vaccine rollout, which needs to see 2 million
vaccinations a week being given for the next six weeks in order
to hit a target of inoculating high priority groups by
mid-February.

Instead, supplies will begin to be delivered to the UK from
the spring once Moderna expands its production capability.

"We have already vaccinated nearly 1.5 million people across
the UK and Moderna's vaccine will allow us to accelerate our
vaccination programme even further once doses become available
from the spring," health minister Matt Hancock said.

Britain now has 17 million doses of Moderna's vaccine on
order, after waiting for trial data before making a commitment,
putting it behind the United States and the European Union in
the queue for the shot.

Moderna's vaccine was 94% effective in preventing disease in
late-stage clinical trials, and it has already been given
regulatory approval for use in the United States, Canada, the
European Union and Israel.

The United States began rolling out the Moderna vaccine in
late December, while the company has said the process will get
underway in the EU next week.

"We appreciate the confidence shown by the UK MHRA in
COVID-19 Vaccine Moderna with this decision," said Stephane
Bancel, Chief Executive Officer of Moderna, referring to the
medicines regulator.

Britain initially prioritised securing doses from Pfizer and
AstraZeneca and was the first country to approve those vaccines,
but has spread its bets and secured doses of 7 different vaccine
candidates in all.

Britain is attempting to vaccinate the elderly, the
vulnerable and frontline workers - around 15 million people - by
mid-February, to ease a new strict lockdown imposed after a
spike in cases to daily records.

Although Moderna's vaccine will not help meet that initial
target, it will help ease supply constraints that Hancock has
cited as being a limiting factor in the rollout.

"This is excellent news and a further crumb of comfort amid
the huge levels of COVID-19 currently circulating around the
UK," said Michael Head, Senior Research Fellow in Global Health
at the University of Southampton.

"When these Moderna vaccines arrive, they will help to ease
any bottlenecks or delays in the administration programme."

(Reporting by Alistair Smout; additional reporting by Kate
Kelland; editing by Guy Faulconbridge, Louise Heavens, Kirsten
Donovan)

More News
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more
21 May 2024 08:18

TOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aim

(Alliance News) - AstraZeneca PLC on Tuesday set out its ambition to achieve USD80 billion in annual revenue by the end of the decade as it signalled a new "era of growth."

Read more
21 May 2024 07:52

LONDON BRIEFING: AstraZeneca plots "new era of growth"; SSP confident

(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, following a mixed close in New York overnight, and tepid trade in Asia.

Read more
21 May 2024 07:34

AstraZeneca lays out plans to hit $80bn in revenues by 2030

(Sharecast News) - AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts significant growth from existing oncology, biopharmaceuticals and rare disease portfolios.

Read more
20 May 2024 11:55

LONDON MARKET MIDDAY: Gold shines amid interest rate cut hopes

(Alliance News) - Stock prices in London got a boost at midday on Monday, as investors eye a key UK inflation reading later in the week, which is expected to show cooling prices.

Read more
20 May 2024 08:56

AstraZeneca to build $1.5-bln cancer drug plant in Singapore

Plans to build ADCs manufacturing facility in Singapore

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.